Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Improvements in liver histology and non-invasive tests are independent of baseline BMI in participants with obesity and MASH: A post hoc analysis from the ESSENCE trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
MASH
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)